These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1391966)

  • 1. Prevention of veno-occlusive disease of the liver after bone marrow transplantation: heparin or no heparin?
    Cahn JY; Flesch M; Brion A; Deconinck E; Leconte Des Floris MF; Voillat L; Plouvier E; Amsallem D; Tiberghien P; Fest T
    Blood; 1992 Oct; 80(8):2149-50. PubMed ID: 1391966
    [No Abstract]   [Full Text] [Related]  

  • 2. [Veno-occlusive disease after bone marrow transplantation: preventive effect of heparin].
    Parquet N; Devergie A; Socié G; Ribaud P; Espérou H; Gluckman E
    Ann Med Interne (Paris); 1997; 148(2):132-5. PubMed ID: 9238437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and treatment of veno-occlusive disease.
    Pegram AA; Kennedy LD
    Ann Pharmacother; 2001; 35(7-8):935-42. PubMed ID: 11485147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of continuous infusion heparin for the prevention of hepatic veno-occlusive disease after bone marrow transplantation.
    Bearman SI; Hinds MS; Wolford JL; Petersen FB; Nugent DL; Slichter SJ; Shulman HM; McDonald GB
    Bone Marrow Transplant; 1990 Jun; 5(6):407-11. PubMed ID: 2369681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
    Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
    Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of hepatic veno-occlusive disease after bone marrow transplantation by continuous infusion of low-dose heparin: a prospective, randomized trial.
    Attal M; Huguet F; Rubie H; Huynh A; Charlet JP; Payen JL; Voigt JJ; Brousset P; Selves J; Muller C
    Blood; 1992 Jun; 79(11):2834-40. PubMed ID: 1586733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Veno-occlusive disease of the liver complicating bone marrow transplantation.
    Baglin TP
    Bone Marrow Transplant; 1994 Jan; 13(1):1-4. PubMed ID: 8019444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic heparin does not prevent liver veno-occlusive disease following autologous bone marrow transplantation.
    Marsa-Vila L; Gorin NC; Laporte JP; Labopin M; Dupuy-Montbrun MC; Fouillard L; Isnard F; Najman A
    Eur J Haematol; 1991 Nov; 47(5):346-54. PubMed ID: 1761121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthotopic liver transplantation for veno-occlusive disease complicating autologous bone marrow transplantation.
    Norris S; Crosbie O; McEntee G; Traynor O; Nolan N; McCann S; Hegarty J
    Transplantation; 1997 May; 63(10):1521-4. PubMed ID: 9175821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Veno-occlusive disease of the liver after bone marrow transplantation. Report of the symposium Autograft in France and the group of study of bone marrow transplantation. France Auto-Greffe et le Groupe d'Etude de la Greffe de Moelle osseuse].
    Rio B; Cahn JY; Attal M; Drouet L; Scrobohaci ML; Degos F; Degott C; Bearman SI; Grañena A; Blaise D
    Presse Med; 1994 Sep 3-10; 23(26):1217-22. PubMed ID: 7831216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A trial use of prostaglandin E1 for prevention of hepatic veno-occlusive disease after allogeneic bone marrow transplantation].
    Morio S; Oh H; Kogure K; Ishii H; Ishii A; Nakaseko C; Ikegami T; Kawano E; Matsuura Y; Nishimura M
    Rinsho Ketsueki; 1994 Sep; 35(9):846-52. PubMed ID: 7967053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of an infant with veno-occlusive disease developed after allogeneic bone marrow transplantation by tissue plasminogen activator, heparin and prostaglandin E1.
    Higashigawa M; Watanabe M; Nishihara H; Tabata N; Azuma E; Ido M; Ito M; Sakurai M
    Leuk Res; 1995 Jul; 19(7):477-80. PubMed ID: 7637394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
    Lee JH; Lee KH; Choi JS; Zang DY; Kim SB; Kim SW; Suh C; Lee JS; Kim WK; Lee YS; Kim SH
    J Korean Med Sci; 1996 Apr; 11(2):118-26. PubMed ID: 8835758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veno-occlusive disease prophylaxis with fresh frozen plasma and heparin in bone marrow transplantation.
    Batsis I; Yannaki E; Kaloyannidis P; Sakellari I; Smias C; Georgoulis I; Fassas A; Anagnostopoulos A
    Thromb Res; 2006; 118(5):611-8. PubMed ID: 16330084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of tissue plasminogen activator in the treatment of veno-occlusive liver disease after bone marrow transplantation.
    Terra SG; Spitzer TR; Tsunoda SM
    Pharmacotherapy; 1997; 17(5):929-37. PubMed ID: 9324182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients.
    Or R; Nagler A; Shpilberg O; Elad S; Naparstek E; Kapelushnik J; Cass Y; Gillis S; Chetrit A; Slavin S; Eldor A
    Transplantation; 1996 Apr; 61(7):1067-71. PubMed ID: 8623187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Percutaneous intrahepatic portosystemic shunting in the treatment of veno-occlusive disease of the liver after bone marrow transplantation].
    Alvarez R; Bañares R; Casariego J; Echenagusía A; Simó G; Alvarez E; Serrano D; Díez-Martín JL
    Gastroenterol Hepatol; 2000 Apr; 23(4):177-80. PubMed ID: 10863859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin.
    Simon M; Hahn T; Ford LA; Anderson B; Swinnich D; Baer MR; Bambach B; Bernstein SH; Bernstein ZP; Czuczman MS; Slack JL; Wetzler M; Herzig G; Schriber J; McCarthy PL
    Bone Marrow Transplant; 2001 Mar; 27(6):627-33. PubMed ID: 11319593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.
    Shulman HM; Fisher LB; Schoch HG; Henne KW; McDonald GB
    Hepatology; 1994 May; 19(5):1171-81. PubMed ID: 8175139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The syndrome of hepatic veno-occlusive disease after marrow transplantation.
    Bearman SI
    Blood; 1995 Jun; 85(11):3005-20. PubMed ID: 7756636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.